Found: 7
Select item for more details and to access through your institution.
Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus.
- Published in:
- Metabolic Syndrome & Related Disorders, 2017, v. 15, n. 6, p. 269, doi. 10.1089/met.2017.0031
- By:
- Publication type:
- Article
Islet Cell Associated Autoantibodies and C-Peptide Levels in Patients with Diabetes and Symptoms of Gastroparesis.
- Published in:
- Frontiers in Endocrinology, 2018, p. 1, doi. 10.3389/fendo.2018.00032
- By:
- Publication type:
- Article
Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?
- Published in:
- Diabetes Care, 2008, v. 31, n. 8, p. 1672, doi. 10.2337/dc08-0167
- By:
- Publication type:
- Article
Sex Differences in Coronary Microvascular Function in Individuals With Type 2 Diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Baroreflex Sensitivity Impairment During Hypoglycemia: Implications for Cardiovascular Control.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes.
- Published in:
- Diabetes, 2015, v. 64, n. 1, p. 236, doi. 10.2337/db14-0670
- By:
- Publication type:
- Article